Cargando…
Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?
Patent foramen ovale (PFO) and cryptogenic stroke (CS) both have a high prevalence. The optimal treatment to reduce stroke recurrence after CS remains controversial. Results from clinical trials, meta-analyses, and position papers, support percutaneous PFO device closure and medical therapy compared...
Autores principales: | Parrini, Iris, Cecchi, Enrico, Forno, Davide, Lyon, Alexander R, Asteggiano, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916420/ https://www.ncbi.nlm.nih.gov/pubmed/33664639 http://dx.doi.org/10.1093/eurheartj/suaa163 |
Ejemplares similares
-
Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023) -
Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017) -
Experience in patent foramen ovale closure with the CERA Lifetech occluder in patients with cryptogenic stroke
por: Węglarz, Przemysław, et al.
Publicado: (2023) -
Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019) -
Patent foramen ovale closure
por: Amin, Zahid
Publicado: (2010)